Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapy

Addition Therapeutics is working on a genetic medicine that would turn a patient’s liver cells into little factories to permanently pump out their own weight loss drugs, the startup told Endpoints News in an exclusive interview.

Raccontata daendpoints.news